Sponsored by:

International Management and Coordination by

 

   

1st International China Biopharmaceutical Symposium (ICBPS)

•• Vaccines, Antibodies and Gene Therapeutics ••

"development, regulatory approval, production, distribution - China and Worldwide"
7 to 11 December 2006
Beijing, China

           Beijing, China. The Chinese Pharmaceutical Association (CPA) and the China Biochemical Pharmaceutical Industry Association (CBPIA), in association with Battelle Memorial Institute, invite the international community to participate in this first symposium in China in the very exciting area of biopharmaceuticals and the market. With the increasing concern in emerging infectious diseases, bioterrorism events and natural disasters, is there enough access to needed active pharmaceutical ingredients (APIs)?  What can China do to sell its products in all markets and what can other countries do to sell their products in China?  How do Western drug and biotech firms get reliable APIs from China and protect their patents and intellectual property (IP)?  How do Western drug and biotech firms work with Chinese firms to introduce and market their products in China?

            The purpose of this symposium is to introduce the medium and smaller sized Western biotech firms and the regulatory communities, to the Chinese Biopharmaceutical Industries. Learn each others’ capabilities and capacities for product development and manufacturing. Learn the technical, scientific, medical and legal aspects of the processes associated with research and development, drug discovery; and developing and bringing biopharmaceuticals and pharmaceuticals to market in China and in the West.


          The final formal Planning Meeting took place in Beijing from 22-25 October 2006. At this meeting over 75 Abstracts were reviewed and podium and/or poster presentation sessions were assigned. Please note these assignments are tentative but changes will be relatively minor. Presenters will be notified of changes that effect them. Poster presentations will be listed within next two weeks; however, if presentation is not listed for Podium, please assume the presentation will be from Poster. (Poster board size is 90cm width and 200cm high.)

          For all ICBPS presenters, podium and/or poster, send by e-mail a current photo, approximately 1.5 inches by 1.5 inches or 4cm by 4 cm (approximately). Additionally - please send in a paragraph of not more than 75 words on yourself to include organization, duties, etc. We will try and give one page in the program to each presenter. This page will include the Abstract, photo, bio and empty space for each participant to write notes on the presentation. This has worked very well for us in the past at CBMTS meetings.

          This must be in to us by close of business on 20 November at the latest. And please put ICBPS in the subject line of your message and please send copy to our CPA Hosts at: sinopharmacy@163.net and gjh6565@163.com.

The Program:



Latest Abstracts Submitted:

"Breakthrough Technology for Large-Scale Protein Production with Transient Transfection using CHO Suspension Cultures"
Jack Zhai, PhD

"The many faces of H5N1 - applying an understanding of pathology and pathogenesis towards the development of novel Biopharmaceuticals."
Dr. Aileen Marty, M.D.

"Using Near Infraread (NIR) Analyzers for Real-Time Applications in Pharmaceutical and Biopharmaceutical Production"
Igor Nazarov, Brimrose Corporation of America, US


 

International Executive Committee

  • Mason Soule, Battelle, USA
  • Liu, Chunguang, Chinese Pharmaceutical Association, China
  • Richard M. Price, ASA, USA
  • Steve Bice, Battelle, USA
  • Mick Garstang, Acambis plc, UK
  • Dr. Mildred Donlon, DARPA, USA

International Science Review Committee

  • Dr. David Robinson, Battelle, USA
  • Dr. Barbara B. S. Price, ASA, USA
  • Dr. James Estep, Battelle, USA
  • Dr. Mohammed Al-Ahdal, SFDA, Saudi Arabia
  • Dr. Ben Prickril, KenGar Consultants, France
  • Dr John (Jack) Woodall, Federal University of Rio de Janeiro, Brazil
  • Dr. Jerome Donlon, DHHS, USA
  • Dr. David Moore, AMRICD, USA

Chinese Science Review Committee

  • Dr. Wang, Youchun, Institute for the Control of Pharmaceutical and Biological Products
  • Dr. Cao, Cheng, Beijing Institute of Biotechnology
  • Dr. Shen, Xing Liang, National Vaccine and Serum Institute
  • Prof. Wang, Fuqing, China Biochemical Pharmaceutical Industry Association 

Updated by Evan Saunders, 6 November 2006
copyright©2006, ASA Inc. All rights reserved